JPMorgan Chase Ceases to Be Substantial Holder in DUG Technology
JPMorgan Chase & Co. and its affiliates have announced they are no longer a substantial shareholder in DUG Technology Ltd, effective April 15, 2026. This change resulted from transactions including rehypothecation of client securities under a prime brokerage agreement and principal trading by J.P. Morgan Securities entities. The administrative notice indicates a shift in DUG Technology's institutional investor base, which could be monitored by investors for potential impacts on liquidity and support, though it does not directly affect the company's operations.
HYG ETF Maintains Stable Monthly Distributions Amid Fed Rate Cuts
The iShares iBoxx $ High Yield Corporate Bond ETF (HYG) continues to provide stable monthly distributions to investors, ranging from $0.36 to $0.41 per share, supported by a resilient macroeconomic environment including a 4.3% unemployment rate. This stability is maintained despite Federal Reserve interest rate cuts, which have helped mitigate refinancing pressures for leveraged companies within the ETF's portfolio. With a market capitalization nearing $18 billion, HYG remains a significant bond ETF, tracking the Markit iBoxx USD Liquid High Yield Index and offering consistent income while its shares have gained nearly 10% in value over the past year.
News Corp cancels 201,601 Class B shares in ASX buy-back move
News Corporation has cancelled 201,601 ASX-listed Class B shares through a buy-back, effective April 17, 2026. This move slightly reduces the company's issued capital, signaling active capital management aimed at enhancing shareholder value. An analyst has rated AU:NWS stock a "Buy" with a A$50.00 price target.
Skillsoft (NYSE:SKIL) Stock Forecast & Analyst Predictions
This article provides a stock forecast and analyst predictions for Skillsoft (NYSE:SKIL). It notes a lack of sufficient analyst coverage to forecast immediate growth and revenue, yet details numerous past and projected earnings and revenue guidance updates. The report also includes financial data from analysts forecasting revenue, earnings, free cash flow, and cash from operations through early 2027.
Leidos Holdings Inc stock (US5253271028): Why Google Discover changes matter more now
Google's 2026 Discover Core Update, completed on February 27, 2026, is profoundly changing how investors access news about Leidos Holdings Inc (LDOS). The update decouples Discover from traditional search, prioritizing personalized mobile feeds based on user activity, location, and content engagement. This shift provides investors with earlier access to critical developments concerning Leidos' defense contracts, cybersecurity advancements, and national security tech trends, offering a real-time edge in tracking the stock's performance.
3 Reasons It's Not Too Late to Buy the Dip on Microsoft
Despite a recent dip of over 20% from its October 2025 all-time high, Microsoft's stock presents a compelling long-term buying opportunity. The company is well-positioned to navigate the AI revolution by integrating AI into its products, and its business model with a significant portion of recurring revenue and strong financials makes it resilient to economic downturns. Furthermore, even with its recent recovery, Microsoft's shares are considered reasonably valued compared to its Magnificent Seven peers, making it an attractive investment for the long term.
Revenue per share of Prestige Consumer Healthcare Inc – FWB:PBV
This article provides financial information for Prestige Consumer Healthcare Inc. (FWB:PBV) listed on the Frankfurt Stock Exchange, specifically focusing on its revenue per share. It mentions market data from ICE Data Services and reference data from FactSet. The content indicates that the market is currently closed
Pacific Biosciences of California reveals unified approach to structural variant detection in cancer research
Pacific Biosciences of California (PacBio) is advancing cancer drug research and development by introducing its HiFi sequencing technology, which offers a unified view of structural variants and isoforms often missed by traditional methods. This technology aims to accelerate innovation in cancer therapeutics. Additionally, PacBio launched its SMRT Grant program to support researchers utilizing its sequencing solutions in oncology.
QXO to Acquire TopBuild In $17 Billion Deal
QXO Inc. announced its intent to acquire TopBuild Corp. for approximately $17 billion, a deal expected to close in Q3 2026. This acquisition will make QXO the second-largest publicly traded building products distributor in North America, significantly expanding its market reach into the $90+ billion insulation market and increasing its exposure to large-scale projects. The combined company is projected to generate over $18 billion in annual revenue and achieve $300 million in synergies by 2030.
CapEx per share of Crown Castle Inc. – VIE:CCIN
This page displays information about the Capital Expenditure (CapEx) per share for Crown Castle Inc. (CCIN) on the Vienna Stock Exchange. It includes an overview of financial data, news, community insights, forecasts, and seasonal trends related to the company.





